BFEB vs MRNY
Innovator US Equity Buffer ETF - February vs YieldMax MRNA Option Income Strategy ETF
Which is better, BFEB or MRNY?
MRNY has been ahead.
BFEB has a lower expense ratio. MRNY led over 1Y, 3Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BFEB | MRNY |
|---|---|---|
| Expense Ratio | 0.79%Best | 1.00% |
| AUM | $208M | $243M |
| Dividend Yield | 0.00% | 41.90% |
| Holdings | 18 | 31 |
| YTD Return | +11.67% | +447.17%Best |
| 1Y Return | +15.60% | +503.56%Best |
| 3Y Return (annualized) | +17.04% | +21.31%Best |
| 5Y Return (annualized) | +11.68% | - |
| Volatility (annualized) | 8.1%Best | 98.5% |
| Max Drawdown | -13.8%Best | -82.2% |
| $10,000 over 3 years | $16,493 | $17,852Best |
| Fund Family | Innovator ETFs Trust | YieldMax ETF |
| Category | Alternative | Alternative |
| Style | Multi Alternative | Multi Alternative |
| Inception | Feb 3, 2020 | Oct 23, 2023 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 3 years row, are measured over the window both funds cover: Oct 24, 2023 to Oct 14, 2026 (3 years).
BFEB vs MRNY growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 3 years both funds cover.
BFEB vs MRNY Performance
Innovator US Equity Buffer ETF - February (BFEB) is an ETF from Innovator ETFs Trust and YieldMax MRNA Option Income Strategy ETF (MRNY) is an ETF from YieldMax ETF. Over the past year BFEB returned +15.60% while MRNY returned +503.56%. Year to date, BFEB is up 11.67% versus a gain of 447.17% for MRNY.
Over three years, BFEB compounded at +17.04% per year against +21.31% for MRNY.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
MRNY has been the more volatile fund, with annualized monthly volatility of 98.5% compared with 8.1% for BFEB. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -13.8% for BFEB and -82.2% for MRNY. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.02. They move largely independently of each other.
Fees and Cost Over Time
BFEB charges 0.79% per year while MRNY charges 1.00%. On a $10,000 position that is $79 vs $100 annually, a gap of $21 per year that compounds over a long holding period. On income, BFEB currently yields 0.00% against 41.90% for MRNY.
You are not choosing between two funds in isolation.
Whichever of BFEB and MRNY you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BFEB or MRNY?
BFEB has an expense ratio of 0.79% while MRNY charges 1.00%. BFEB is the cheaper option, by $21 a year on a $10,000 investment.
Which performed better, BFEB or MRNY?
Over the past year BFEB returned +15.60% vs +503.56% for MRNY, so MRNY leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BFEB or MRNY?
MRNY has been the more volatile fund at 98.5% annualized versus 8.1% for BFEB. Worst drawdown: BFEB -13.8% vs MRNY -82.2%.
Should I hold both BFEB and MRNY?
BFEB and MRNY have a monthly-return correlation of 0.02, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, BFEB or MRNY?
BFEB yields 0.00% while MRNY yields 41.90%, so MRNY currently pays the higher dividend yield.
Is MRNY better than BFEB?
BFEB has a lower expense ratio. MRNY led over 1Y, 3Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.